Safety and tolerability of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis: 2-year data from the ADVANCE study

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2014
This article has no abstract
Epistemonikos ID: 8ab68130a7a94ec2867b7278681e3bdfe5d8aeb9
First added on: Apr 30, 2026